Pacific Biosciences of California (PACB) 8-K Results of Operations and Financial Condition

Exhibit 99.2

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

	Years Ended December 31,
(in thousands, except per share amounts)	2012			2011			2010
Revenue:
Product revenue	$	20,089		$	31,486		$	—
Service and other revenue		4,959			1,487			—
Grant revenue		935			890			1,674
Total revenue		25,983			33,863			1,674
Cost of Revenue:
Cost of product revenue		18,796			18,725			—
Cost of service and other revenue		6,247			2,104			—
Total cost of revenue		25,043			20,829			—
Gross profit		940			13,034			1,674
Operating Expense:
Research and development		47,623			76,080			111,821
Sales, general and administrative		47,655			46,710			30,087
Total operating expense		95,278			122,790			141,908
Operating loss		(94,338	)		(109,756	)		(140,234	)
Other income, net		(127	)		368			68
Net loss	$	(94,465	)	$	(109,388	)	$	(140,166	)
Basic and diluted net loss per share	$	(1.69	)	$	(2.03	)	$	(14.10	)
Shares used in computing basic and diluted net loss per share		55,733			53,874			9,938
Comprehensive loss	$	(94,491	)	$	(109,310	)	$	(140,188	)